Charcot foot syndrome

被引:51
作者
Jeffcoate, W. J. [1 ]
机构
[1] Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Endocrinol & Diabet, Nottingham, England
关键词
GENE-RELATED PEPTIDE; DIABETIC-PATIENTS; NEUROPATHIC OSTEOARTHROPATHY; NATURAL-HISTORY; BONE; NEUROARTHROPATHY; CALCITONIN; ARTHROPATHY; ANKLE; DIFFERENTIATION;
D O I
10.1111/dme.12754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Charcot foot syndrome is an uncommon complication of diabetes but is potentially devastating in its consequences. Outcome is made worse by widespread professional ignorance leading to delayed diagnosis, but it is also hampered by lack of understanding of its causes and lack of treatments with proven effectiveness, other than offloading. There remains a desperate need for studies into its causes as well as comparative audit and trials designed to determine the best treatment for this difficult condition. Such work can probably only be effectively carried out through the establishment of multicentre networks. Nevertheless, improved understanding in recent years of the likely role of inflammatory pathways has raised awareness of the multiple ways in which the effects of neuropathy may be manifest in the development of the Charcot foot. This awareness is also leading to the realization that similar processes may conceivably contribute to the refractoriness of other foot diseases in diabetes, including both chronic unhealing ulcers and osteomyelitis.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 87 条
[1]   Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds - A randomized controlled trial [J].
Armstrong, DG ;
Lavery, LA ;
Wu, S ;
Boulton, AJM .
DIABETES CARE, 2005, 28 (03) :551-554
[2]  
Armstrong DG, 1997, DIABETIC MED, V14, P357, DOI 10.1002/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO
[3]  
2-8
[4]   Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy [J].
Baker, Neil ;
Green, Alistair ;
Krishnan, Singhan ;
Rayman, Gerry .
DIABETES CARE, 2007, 30 (12) :3077-3079
[5]  
Barbaro D, 2008, MINERVA ENDOCRINOL, V33, P283
[6]   Charcot Arthropathy of the Foot and Ankle in Patients With Idiopathic Neuropathy [J].
Bariteau, Jason T. ;
Tenenbaum, Shay ;
Rabinovich, Alexander ;
Brodsky, James W. .
FOOT & ANKLE INTERNATIONAL, 2014, 35 (10) :996-1001
[7]   Imaging of lower extremity artery atherosclerosis in diabetic foot - FDG-PET imaging and histopathological correlates [J].
Basu, Sandip ;
Zhuang, Hongming ;
Alavi, Abass .
CLINICAL NUCLEAR MEDICINE, 2007, 32 (07) :567-568
[8]   Cytokine-induced osteoclastic bone resorption in Charcot arthropathy: An immunohistochemical study [J].
Baumhauer, Judith F. ;
O'Keefe, Regis J. ;
Schon, Lew C. ;
Pinzur, Michael S. .
FOOT & ANKLE INTERNATIONAL, 2006, 27 (10) :797-800
[9]   Sclerostin Inhibition for Osteoporosis - A New Approach [J].
Becker, Carolyn B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05) :476-477
[10]   Intranasal calcitonin in the treatment of acute charcot neuroosteoarthropathy -: A randomized controlled trial [J].
Bem, Robert ;
Jirkovska, Alexandra ;
Fejfarova, Vladimira ;
Skibova, Jelena ;
Jude, Edward B. .
DIABETES CARE, 2006, 29 (06) :1392-1394